At the Heart of Immune checkpoint Inhibitor-Induced Immune Toxicity

被引:2
作者
Young, Arabella [1 ,2 ,3 ]
Bluestone, Jeffrey A. [1 ,2 ,4 ]
机构
[1] Univ Calif San Francisco, Sean N Parker Autoimmune Res Lab, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA
[3] QIMR Berghofer Med Res Inst, Herston, Qld, Australia
[4] Sonoma Biotherapeut, San Francisco, CA USA
基金
澳大利亚国家健康与医学研究理事会;
关键词
D O I
10.1158/2159-8290.CD-21-0091
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Wei and colleagues showcase a genetic mouse model of immune-mediated myocarditis that shares homology with immune checkpoint inhibitor (CPI)-induced myocarditis in patients with cancer. They demonstrate that abatacept (CTLA4-Ig) limits cardiac toxicity in the mouse model and, thus, may ameliorate the CPI-induced myocarditis in patients with cancer while potentially maintaining antitumor activity.
引用
收藏
页码:537 / 539
页数:3
相关论文
共 11 条
[1]   Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody [J].
Iwama, Shintaro ;
De Remigis, Alessandra ;
Callahan, Margaret K. ;
Slovin, Susan F. ;
Wolchok, Jedd D. ;
Caturegli, Patrizio .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (230)
[2]   Fulminant Myocarditis with Combination Immune Checkpoint Blockade [J].
Johnson, Douglas B. dbj ;
Balko, Justin M. jmb ;
Compton, Margaret L. mlc ;
Chalkias, Spyridon sc ;
Gorham, Joshua jc ;
Xu, Yaomin yx ;
Hicks, Mellissa mh ;
Puzanov, Igor ip ;
Alexander, Matthew R. mra ;
Bloomer, Tyler L. tlb ;
Becker, Jason R. jrb ;
Slosky, David A. das ;
Phillips, Elizabeth J. ejp ;
Pilkinton, Mark A. map ;
Craig-Owens, Laura lco ;
Kola, Nina nk ;
Plautz, Gregory gp ;
Reshef, Daniel S. dsr ;
Deutsch, Jonathan S. jsd ;
Deering, Raquel P. rpd ;
Olenchock, Benjamin A. bao ;
Lichtman, Andrew H. ahl ;
Roden, Dan M. dmr ;
Seidman, Christine E. ces ;
Koralnik, Igor J. ijk ;
Seidman, Jonathan G. jgs ;
Hoffman, Robert D. rdh ;
Taube, Janis M. jmt ;
Diaz, Luis A. Jr lad ;
Anders, Robert A. raa ;
Sosman, Jeffrey A. jas ;
Moslehi, Javid J. jjm .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18) :1749-1755
[3]   Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer [J].
Liu, Jing ;
Blake, Stephen J. ;
Harjunpaa, Heidi ;
Fairfax, Kirsten A. ;
Yong, Michelle C. R. ;
Allen, Stacey ;
Kohrt, Holbrook E. ;
Takeda, Kazuyoshi ;
Smyth, Mark J. ;
Teng, Michele W. L. .
CANCER RESEARCH, 2016, 76 (18) :5288-5301
[4]   Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody [J].
Maher, V. Ellen ;
Fernandes, Laura L. ;
Weinstock, Chana ;
Tang, Shenghui ;
Agarwal, Sundeep ;
Brave, Michael ;
Ning, Yang-min ;
Singh, Harpreet ;
Suzman, Daniel ;
Xu, James ;
Goldberg, Kirsten B. ;
Sridhara, Rajeshwari ;
Ibrahim, Amna ;
Theoret, Marc ;
Beaver, Julia A. ;
Pazdur, Richard .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (30) :2730-+
[5]   Myocarditis in Patients Treated With Immune Checkpoint Inhibitors [J].
Mahmood, Syed S. ;
Fradley, Michael G. ;
Cohen, Justine V. ;
Nohria, Anju ;
Reynolds, Kerry L. ;
Heinzerling, Lucie M. ;
Sullivan, Ryan J. ;
Damrongwatanasuk, Rongras ;
Chen, Carol L. ;
Gupta, Dipti ;
Kirchberger, Michael C. ;
Awadalla, Magid ;
Hassan, Malek Z. O. ;
Moslehi, Javid J. ;
Shah, Sachin P. ;
Ganatra, Sarju ;
Thavendiranathan, Paaladinesh ;
Lawrence, Donald P. ;
Groarke, John D. ;
Neilan, Tomas G. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (16) :1755-1764
[6]   PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin [J].
Miao, Xiao ;
Xu, Rong ;
Fan, Bin ;
Chen, Jie ;
Li, Xin ;
Mao, Weiwei ;
Hua, Shengyuan ;
Li, Bin .
SCIENTIFIC REPORTS, 2018, 8
[7]   Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy [J].
Perez-Ruiz, Elisabeth ;
Minute, Luna ;
Otano, Itziar ;
Alvarez, Maite ;
Carmen Ochoa, Maria ;
Belsue, Virginia ;
de Andrea, Carlos ;
Esperanza Rodriguez-Ruiz, Maria ;
Luis Perez-Gracia, Jose ;
Marquez-Rodas, Ivan ;
Llacer, Casilda ;
Alvarez, Martina ;
de Luque, Vanesa ;
Molina, Carmen ;
Teijeira, Alvaro ;
Berraondo, Pedro ;
Melero, Ignacio .
NATURE, 2019, 569 (7756) :428-+
[8]   BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains [J].
Weaver, James L. ;
Zadrozny, Leah M. ;
Gabrielson, Kathleen ;
Semple, Kenrick M. ;
Shea, Katherine I. ;
Howard, Kristina E. .
TOXICOLOGICAL SCIENCES, 2019, 169 (01) :194-208
[9]   A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitors-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention [J].
Wei, Spencer C. ;
Meijers, Wouter C. ;
Axelrod, Margaret L. ;
Anang, Nana-Ama A. S. ;
Screever, Elles M. ;
Wescott, Elizabeth C. ;
Johnson, Douglas B. ;
Whitley, Elizabeth ;
Lehmann, Lorenz ;
Courand, Pierre-Yves ;
Mancuso, James J. ;
Himmel, Lauren E. ;
Lebrun-Vignes, Benedicte ;
Wleklinski, Matthew J. ;
Knollmann, Bjorn C. ;
Srinivasan, Jayashree ;
Li, Yu ;
Atolagbe, Oluwatomisin T. ;
Rao, Xiayu ;
Zhao, Yang ;
Wang, Jing ;
Ehrlich, Lauren I. R. ;
Sharma, Padmanee ;
Salem, Joe-Elie ;
Balko, Justin M. ;
Moslehi, Javid J. ;
Allison, James P. .
CANCER DISCOVERY, 2021, 11 (03) :614-625
[10]   Developing syngeneic NOD tumor models to profile immunotoxicity and antitumor immunity in response to cancer immunotherapies in autoimmune-prone mice [J].
Young, Arabella ;
Nguyen, Vinh ;
Kang, Jee Hye ;
Mehdizadeh, Sadaf ;
Mei, Amy ;
Sheehan, Kathleen C. F. ;
Serreze, David V. ;
Chen, Yi-Guang ;
Schreiber, Robert D. ;
Bluestone, Jeffrey A. .
CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)